Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021)

NATURE MEDICINE

卷 -, 期 -, 页码 -

NATURE PORTFOLIO

-

Biochemistry & Molecular Biology Cell Biology Medicine, Research & Experimental